Cryptic Microheteroresistance Explains Mycobacterium tuberculosis Phenotypic Resistance

被引:30
|
作者
Metcalfe, John Z. [1 ]
Streicher, Elizabeth [2 ,3 ]
Theron, Grant [2 ,3 ]
Colman, Rebecca E. [4 ]
Allender, Christopher [5 ]
Lemmer, Darrin [5 ]
Warren, Rob [2 ,3 ]
Engelthaler, David M. [5 ]
机构
[1] Univ Calif San Francisco, San Francisco Gen Hosp, Div Pulm & Crit Care Med, 1001 Potrero Ave,Rm 5K1, San Francisco, CA 94110 USA
[2] Stellenbosch Univ, Fac Med & Hlth Sci, DST NRF Ctr Excellence Biomed TB Res, Tygerberg, South Africa
[3] Stellenbosch Univ, Fac Med & Hlth Sci, SAMRC Ctr TB Res, Div Mol Biol & Human Genet, Tygerberg, South Africa
[4] Univ Calif San Diego, Div Pulm Crit Care & Sleep Med, San Diego, CA 92103 USA
[5] Translat Genom Res Inst, Flagstaff, AZ USA
基金
英国医学研究理事会; 新加坡国家研究基金会;
关键词
next-generation sequencing; Sanger sequencing; drug-resistant tuberculosis; diagnostics; DRUG-RESISTANCE; FLUOROQUINOLONE RESISTANCE; STREPTOCOCCUS-PNEUMONIAE; HETERO-RESISTANCE; GENOMIC ANALYSIS; SOUTH-AFRICA; HETERORESISTANCE; SUSCEPTIBILITY; MUTATIONS; DIAGNOSIS;
D O I
10.1164/rccm.201703-0556OC
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Rationale: Minority drug-resistant Mycobacterium tuberculosis subpopulations can be associated with phenotypic resistance but are poorly detected by Sanger sequencing or commercial molecular diagnostic assays. Objectives: To determine the role of targeted next-generation sequencing in resolving these minor variant subpopulations. Methods: We used single molecule overlapping reads (SMOR), a targeted next-generation sequencing approach that dramatically reduces sequencing error, to analyze primary cultured isolates phenotypically resistant to rifampin, fluoroquinolones, or aminoglycosides, but for which Sanger sequencing found no resistance-associated variants (RAVs) within respective resistance-determining regions (study group). Isolates also underwent single-colony selection on antibiotic-containing agar, blinded to sequencing results. As a positive control, isolates with multiple colocalizing chromatogram peaks were also analyzed (control group). Measurements and Main Results: Among 61 primary culture isolates (25 study group and 36 control group), SMOR described 66 (49%) and 45 (33%) of 135 total heteroresistant RAVs at frequencies less than 5% and less than 1% of the total mycobacterial population, respectively. In the study group, SMOR detected minor resistant variant subpopulations in 80% (n = 20/25) of isolates with no Sanger-identified RAVs (median subpopulation size, 1.0%; interquartile range, 0.2-3.9%). Single-colony selection on drug-containing media corroborated SMOR results for 90% (n = 18/20) of RAV-containing specimens, and the absence of RAVs in 60% (n = 3/5) of isolates. Overall, Sanger sequencing was concordant with SMOR for 77% (n = 53/69) of macroheteroresistant (5-95% total population), but only 5% of microheteroresistant (< 5%) subpopulations (n = 3/66) across both groups. Conclusions: Cryptic minor variant mycobacterial subpopulations exist below the resolving capability of current drug susceptibility testing methodologies, and may explain an important proportion of false-negative resistance determinations.
引用
收藏
页码:1191 / 1201
页数:11
相关论文
共 50 条
  • [41] Transmission of Mycobacterium tuberculosis presenting unusually high discordance between genotypic and phenotypic resistance to rifampicin in an endemic tuberculosis setting
    Brandao, Angela Pires
    Watanabe Pinhata, Juliana Maira
    Simonsen, Vera
    Oliveira, Rosangela Siqueira
    Ghisi, Kelen Teixeira
    Silva Rabello, Michelle Christiane
    Fukasava, Suely
    Ferrazoli, Lucilaine
    TUBERCULOSIS, 2020, 125
  • [42] RESISTANCE PATTERN OF MYCOBACTERIUM TUBERCULOSIS AND MYCOBACTERIUM BOVIS TO ETHAMBUTOL
    TSUKAMUR.M
    ACTA TUBERCULOSEA ET PNEUMOLOGICA SCANDINAVICA, 1965, 46 (02): : 89 - &
  • [43] Onset of infectiousness explains differences in transmissibility across Mycobacterium tuberculosis lineages
    Windels, Etthel M.
    Agui, Cecilia Valenzuela
    de Jong, Bouke C.
    Meehan, Conor J.
    Loiseau, Chloe
    Goig, Galo A.
    Zwyer, Michaela
    Borrell, Sonia
    Brites, Daniela
    Gagneux, Sebastien
    Stadler, Tanja
    EPIDEMICS, 2025, 51
  • [44] Genotypic and phenotypic drug resistance patterns of Mycobacterium tuberculosis isolated from presumptive pulmonary tuberculosis patients in Ethiopia: A multicenter study
    Yenew, Bazezew
    Kebede, Abebaw
    Alemu, Ayinalem
    Diriba, Getu
    Mehammed, Zemedu
    Amare, Misikir
    Dagne, Biniyam
    Sinshaw, Waganeh
    Tesfaye, Ephrem
    Beyene, Dereje
    Abegaz, Woldaregay Erku
    PLOS ONE, 2024, 19 (05):
  • [45] Rifampin resistance missed in phenotypic drug susceptibility testing for Mycobacterium tuberculosis isolates with disputed rpoB mutations
    Huh, H. J.
    Koh, W-J.
    Song, D. J.
    Ki, C-S.
    Lee, N. Y.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2015, 45 : S123 - S123
  • [46] Phenotypic and genotypic characteristics of drug resistance in Mycobacterium tuberculosis isolates from pediatric population of Chennai, India
    Therese, K. Lily
    Gayathri, R.
    Balasubramanian, S.
    Natrajan, S.
    Madhavan, H. N.
    INDIAN JOURNAL OF MEDICAL MICROBIOLOGY, 2012, 30 (04) : 411 - 417
  • [47] INDUCED PHENOTYPIC RESISTANCE TO VALINE IN MYCOBACTERIUM PELLEGRINO
    HORVATH, I
    SZENTIRMAI, A
    ZSADANYI, J
    JOURNAL OF BACTERIOLOGY, 1967, 94 (04) : 850 - +
  • [48] The road to drug resistance in Mycobacterium tuberculosis
    Koch, Anastasia
    Wilkinson, Robert John
    GENOME BIOLOGY, 2014, 15 (11):
  • [49] Mechanisms of isoniazid resistance in Mycobacterium tuberculosis
    Barry, CE
    Slayden, RA
    Mludli, K
    DRUG RESISTANCE UPDATES, 1998, 1 (02) : 128 - 134
  • [50] Mycobacterium tuberculosis drug resistance, Ghana
    Owusu-Dabo, Ellis
    Adjei, Ohene
    Meyer, Christian G.
    Horstmann, Rolf D.
    Enimil, Anthony
    Kruppa, Thomas F.
    Bonsu, Frank
    Browne, Edmund N. L.
    Chinbuah, Margaret Amanua
    Osei, Ivy
    Gyapong, John
    Berberich, Christof
    Kubica, Tanja
    Niemann, Stefan
    Ruesch-Gerdes, Sabine
    EMERGING INFECTIOUS DISEASES, 2006, 12 (07) : 1170 - 1172